Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 3 7Phase 1 6Phase NA 2Phase 2/3 1

Status

Unknown 16Recruiting 4Not yet recruiting 3Completed 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 53Saline Solution 49Cyclophosphamide 48Palliative Care 46Yoga 41Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Patient Navigation 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × camrelizumab × Clear all
NCT07053215 2025-07-08

Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC

The First Hospital of Hebei Medical University

Phase NA Completed
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03222440 2019-12-04

Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Completed
20 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡